Physician profile
Gary W Bong
NPI 1093896144
$4,883.24
in general payments reported to CMS, 2019-2025
50 companies · $1,444 in 2025
The $1,444 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $470 · 2021: $580 · 2022: $286 · 2023: $595 · 2024: $1,036 · 2025: $1,444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,074.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $533.16 | 2019-2025 | Xtandi |
| Medtronic USA, INC. | $302.14 | 2019-2020 | |
| Boston Scientific Corporation | $271.71 | 2019-2025 | Rezum Generator, Embold Fibered, Lithovue |
| Biotissue Holdings INC. | $243.04 | 2024-2025 | |
| Janssen Biotech, INC. | $228.60 | 2019-2025 | Erleada, Akeega |
| Medtronic, INC. | $214.93 | 2021-2025 | Interstim, Altaviva |
| Procept Biorobotics Corporation | $209.19 | 2024-2025 | Aquabeam System |
| Abbvie INC. | $198.73 | 2019-2025 | Botox |
| Pfizer INC. | $198.40 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $184.33 | 2019-2025 | Provenge |
| Calyxo, INC. | $164.70 | 2025 | Cvac Aspiration System |
| Teleflex LLC | $143.23 | 2023 | Urolift |
| Sumitomo Pharma America, INC. | $127.45 | 2024-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $127.38 | 2019-2025 | Xyosted |
| Dornier Medtech America, INC | $112.70 | 2025 | Dornier Medtech |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Bong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.